Published on: Jan 01, 2012 at The Lancet

Benefits of Dual Chemo Post-Surgery

By : The Lancet

A study published in a January 2012 issue of The Lancet pertained to “D2 resection,” the surgery that involves removing the primary gastric tumor and lymph nodes around the stomach. The researchers reported that chemotherapy with capecitabine (Xeloda) and oxaliplatin after D2 surgery for patients from Asia with stage 2 or 3 gastric cancer significantly improved disease-free survival compared with D2 surgery alone…

Read More